Injective Foundation 3
3 · Pineapple Financial Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 3
Injective Foundation
10% Owner
Holdings
- 9,615,385
Common Shares
Footnotes (1)
- [F1]The securities reported are held directly by Injective Foundation and may be deemed to be beneficially owned by Glenn Kennedy because Mr. Kennedy, as director of Injective Foundation, has investment and dispositive control of the securities. Mr. Kennedy disclaims beneficial ownership of these securities, has no pecuniary interest in the securities reported, and this form shall not be construed as an admission that he is the beneficial owner of any of the securities reported on this form.